SCHEMBL7274895

SCHEMBL7274895

CCc1cc(N)c(C(=O)O)c(CC)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 3/20 0.44
GABRD O14764 3/20 0.44
GABRA1 P14867 3/20 0.44
GABRB1 P18505 3/20 0.44
GABRG2 P18507 3/20 0.44
GABRB3 P28472 3/20 0.44
GABRA5 P31644 3/20 0.44
GABRA3 P34903 3/20 0.44
GABRA2 P47869 3/20 0.44
GABRB2 P47870 3/20 0.44
GABRA4 P48169 3/20 0.44
GABRE P78334 3/20 0.44
GABRA6 Q16445 3/20 0.44
GABRG1 Q8N1C3 3/20 0.44
GABRG3 Q99928 3/20 0.44
GABRQ Q9UN88 3/20 0.44
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7286429 0.86 NOS3 (0.38) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL3170343 0.82 AGTR1 (0.42) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8875241 0.81 GABRP (0.45) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL16949985 0.81 ALDH1A1 (0.44) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL26688874 0.73 CNKSR1 (0.39) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL18362840 0.72 GABRP (0.44) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL25882373 0.71 ALDH1A1 (0.65) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL3177158 0.71 NOS3 (0.40) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL1424178 0.71 TDP1 (0.43) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7284590 0.71 NOS3 (0.42) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0516392-B1 Naphthyridine derivatives as angiotensin II inhibitors ASTRAZENECA AB (SE) 2001-08-29 EP disclosed
EP-0520724-B1 Angiotensin II antagonists ZENECA LTD (GB) 1995-09-20 EP disclosed
US-5387592-A Angiotensin converting enzyme inhibitors, calcium channel blockers, diuretics and adrenergic blocking agents IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1995-02-07 US disclosed
US-5373015-A Treating hypertension and congestive heart failure IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-12-13 US disclosed
EP-0520723-B1 Angiotensin II antagonists ICI PLC (GB) 1994-06-01 EP disclosed
US-5294620-A Hypotensive agents or compounds for cardiovascular disorders IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-03-15 US disclosed
US-5281613-A Heterocyclic ring substituted benzofuran, benzothiofuran, or indole derivative IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-01-25 US disclosed
WO-1993024501-A1 PHOSPHORUS CONTAINING HETEROCYCLIC COMPOUNDS AS ANGIOTENSINS ANTAGONISTS ZENECA LIMITED (GB) 1993-12-09 WO disclosed
WO-1993024487-A1 NITROGEN CONTAINING HETEROCYCLIC COMPOUNDS AS ANGIOTENSIN-II-ANTAGONISTS ZENECA LIMITED (GB) 1993-12-09 WO disclosed
US-5236937-A Treating hypertension, congestive heart failure IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-08-17 US disclosed
US-5217976-A Hypotensive agents, congestive heart failure IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-06-08 US disclosed
EP-0539066-A1 Heterocyclic compounds useful as angiotensin II antagonists ZENECA LIMITED (GB) 1993-04-28 EP disclosed
EP-0520723-A1 Angiotensin II antagonists IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-12-30 EP disclosed
EP-0520724-A1 Angiotensin II antagonists ZENECA LIMITED (GB) 1992-12-30 EP disclosed
EP-0516392-A2 Naphthyridine derivatives as angiotensin II inhibitors ZENECA LIMITED (GB) 1992-12-02 EP disclosed
EP-0499415-A1 Pyridine and quinoline derivatives, processes for their manufacture and their use as angiotensin II antagonists ZENECA LIMITED (GB) 1992-08-19 EP disclosed